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The coccidian parasite Cryptosporidium is
now recognized as a major cause of waterborne
diarrheal disease worldwide (1,2). The exact
modes of transmission, however, are often
unclear, and the relative importance of foreign
travel; consumption of foods, beverages, or water;
person-to-person transmission; and infected
animals in disease transmission remain to be
ascertained (1,2).
Characterization of Cryptosporidium par-
vum by phenotypic and genotypic methods (3-9)
has identified two major types associated with
human infection: one exclusively from humans
and a single nonhuman primate (genotype 1 or
human type) and a second in livestock as well as
humans (genotype 2 or calf type). Experimental
infection of both calves and mice was successful
with genotype 2 but not with genotype 1 (4).
Polymorphic genes that identify these genotypes
include the Cryptosporidium oocyst wall protein
(COWP) gene (5), the thrombospondin-related
adhesive proteins Cryptosporidium-1 (TRAP-C1
[6]), and Cryptosporidium-2 (TRAP-C2 [4]).
These observations concerning the two genotypes
of C. parvum may reflect the epidemiology of two
parasites with distinct and exclusive transmission
cycles (4,9) and may represent two species (8).
We have described the identification by
polymerase chain reaction-restriction fragment
length polymorphism (PCR-RFLP) of a single
human isolate with an unusual COWP genotype,
designated genotype 3 (10). Several Cryptospo-
ridium species are associated with human
disease, including C. felis, C. meleagridis, and an
as-yet-unnamed species designated the dog type
(11,12). DNA sequencing of multiple genes from
six human isolates of COWP genotype 3 indicates
that separate species status is justified; its 18S
rDNA sequences are identical to those of
C. meleagridis (13). Since the host range of the
various Cryptosporidium species and C. parvum
genotypes infectious to humans differs, their
epidemiology is also likely to differ.
We have described a simple DNA extraction
method from whole feces, suitable for amplifica-
tion of Cryptosporidium DNA, and have applied
it to 397 cryptosporidiosis cases, including
sporadic human and animal cases as well as cases
from two large waterborne outbreaks (8,10). In
218 sporadic human cases, DNA could not be
amplified from 9% of samples for genotyping by
PCR-RFLP analysis of the COWP gene (5,8),
despite amplification of 18S rDNA fragments or
detection of oocysts by microscopy. The purposes
of this study were to develop sensitive methods
for identifying Cryptosporidium genotypes in
DNA extracted from whole feces and to assess the
application of these techniques to large numbers
of samples.
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We developed a sensitive nested polymerase chain reaction procedure for the
Cryptosporidium oocyst wall protein (COWP) gene. Amplification and genotyping were
successful in 95.2% of 1,680 fecal samples, 77.6% by the unnested and 17.6% by the
nested COWP procedure. The COWP gene was amplified from 2,128 fecal samples: 71
from livestock animals and 2,057 from humans. This series included 706 cases from
seven drinking water-associated outbreaks and 51 cases from five swimming pool-
associated outbreaks, as well as 1,300 sporadic cases.50 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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Materials and Methods
Fecal Samples, Oocyst Disruption,
and DNA Extraction
Whole feces were collected from naturally
infected humans and livestock animals; the
samples contained Cryptosporidium  oocysts
morphologically indistinguishable from C. parvum
by light microscopy (8,14). One sample of feces
from a sheep experimentally infected with a
standard (Moredun) strain originally of cervine
origin (15) was included. Human feces were also
tested in which no Cryptosporidium was detected
but  Cyclospora oocysts or Giardia cysts were
detected by conventional techniques. All speci-
mens were stored at 4°C without preservatives.
Oocyst disruption and DNA purification were
performed (8).
Staining and Light Microscopy
Samples were reexamined by light micros-
copy after being stained by the modified Ziehl-
Neelsen (MZN) acid-fast method (14) and the
immunofluorescence (IF) method (8) with an
anti-Cryptosporidium-oocyst monoclonal anti-
body designated MAB-C1 (16).
PCR-RFLP analysis
PCR of two 18S rDNA fragments (reaction 1
[8,17] and reaction 2 [18]), COWP (5), TRAP-C1
(6), and TRAP-C2 (4) gene fragments, as well as
restriction digestion with RsaI for the COWP and
TRAP-C1 genes, was performed. The 18S rDNA
reaction 2 (18) was modified as described by
Bornay-Llinares et al. (19) to include 4 mM
MgCl2, with a program cycle of 95°C for 5 min, 45
cycles of 94°C for 30 sec, 65°C for 30 sec, and 72°C
for 1 min, followed by a final extension at 72°C for
9 min.
For the nested-COWP procedure (N-COWP),
a 769-bp fragment of the COWP gene was
amplified with primers BCOWPF (5'-ACCGCT
TCTCAACAACCATCTTGTCCTC-3') and
BCOWPR (5'-CGCACCTGTTCCCACTCAATGTA
AACCC-3'), which encompasses the 553-bp
fragment (5). Primers BCOWPNF and BCOWPNR
were designed by using the PRIME program in
the Genetics Computer Group Wisconsin pack-
age (Madison, WI). PCR amplification was
performed in 25-µl volumes with 2.5 µl of DNA in
1x PCR buffer, 1.5 mM MgCl2, 250 µM of each
dNTP, 10 pmoles of each primer, and 1.25 units of
Taq DNA polymerase. Samples were subjected to
30 cycles of 94°C for 1 min, 65°C for 1 min, and
72°C for 1 min, followed by a final extension at
72°C for 10 min. This single reaction is referred to
as the extended-COWP (E-COWP) reaction. For
the N-COWP procedure, a 553-bp gene fragment
was then amplified from 2.5 µl of the E-COWP
material as described (5), except that each primer
(Cry9 and Cry15) was used at 10 pmoles. Positive
and negative controls for all PCR procedures
were included at all stages and for all batches.
For the N-COWP, E-COWP, COWP, 18S
rDNA 1, 18S rDNA 2, TRAP-C1, and TRAP-C2
gene fragments, 5-µl aliquots of the PCR
products were analyzed by electrophoresis in 1%
agarose-ethidium bromide gels. RsaI digestion of
N-COWP, COWP, and TRAP-C1 fragments was
resolved by electrophoresis in 3.2% typing-grade
agarose gels containing ethidium bromide. All
gels were recorded by using UV transillumina-
tion and Polaroid Type 667 film.
DNA Sequencing
PCR products were purified in Microspin S-
400 HR (Pharmacia Biotech, St. Albans, UK) and
cloned by using the TOPO-TA Cloning kit
(Invitrogen, Groningen, the Netherlands). Plas-
mid DNA was purified by using the Promega
Wizard SV kit (Promega, Madison, WI), and
clones were sequenced on an ABI377 automated
sequencer with BigDye terminator chemistry
with the M13(-21) primer at the Single Reaction
DNA Sequencing Service (Cambridge Bioscience
Ltd., Cambridge, UK). Sequences were analyzed
with the Genetics Computer Group (GCG)




Analysis of the published genotype 2 COWP
gene sequence (GenBank accession numbers
Z22537) led to design of two primers (BCOWPF
and BCOWPR) to amplify a predicted E-COWP
769-bp fragment, which includes the 553-bp
fragment amplified by the previously described
Cry15/Cry9 primers (5). Appropriately sized
fragments were generated by using the BCOWPF
and BCOWPR primer pair from DNA extracted
from human fecal samples containing
Cryptosporidium genotypes 1, 2, and 3. The three
respective amplicons were cloned and sequenced;
the sequences are available from GenBank:51 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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accession numbers af248741 (genotype 1),
af248743 (genotype 2), and af248742 (genotype
3). Identical sequences were obtained from the
genotype 2 sequence (accession number Z22537),
with the exception of the insertion of three
nucleotides.
The N-COWP amplification procedure for the
553-bp COWP fragment from the 769-bp E-
COWP amplicon was developed and initially
assessed by using 76 DNA samples extracted
from whole human feces, which had been
genotyped by using the COWP reaction. Identical
results were obtained by the COWP and
N-COWP procedures: 28 were genotype 1, 34
genotype 2, and 5 genotype 3; both genotypes 1
and 2 were recovered from nine samples. No
amplicons were detected by the N-COWP
procedure with DNA extracted from Toxoplasma
gondii tachyzoites (two samples), Eimeria tenella
oocysts (two samples), and feces containing
either  Cyclospora oocysts (10 samples) or
Giardia cysts (11 samples).
N-COWP by Different PCR Procedures
To assess the sensitivity of PCR procedures
for the N-COWP reaction, amplification of DNA
was compared with that from the E-COWP,
COWP, TRAP-C1, and TRAP-C2, as well as the
two 18S rDNA reactions. DNA samples prepared
from whole feces were decimally diluted in water
to 10-4, and each dilution was tested by all
procedures. Samples were prepared from human
feces containing genotypes 1, 2, or 3 and from
ovine feces (Moredun strain) containing genotype
2 (Table 1).
The N-COWP reaction strongly amplified
DNA from all samples to a dilution of 10-3, with
the exception of the genotype 3 sample, in which
Table 1. Sensitivities of different polymerase chain reaction procedures for Cryptosporidium gene sequences
Dilutions of PCR procedurea
DNA sample N-COWP E-COWP COWP TRAP-C1 TRAP-C2 18S rDNA 1 18s rDNA 2
Human, genotype 1
Undiluted +++b ++ ++ ++ ++ ++ ++
10-1 +++ ++ ++ ++ ++ ++ ++
10-2 +++ + ++ — + + ++
10-3 + + +—— —— + + +
10-4 —— —— —— —
Human, genotype 2
Undiluted +++ ++ ++ ++ ++ ++ ++
10-1 +++ + ++ + — ++ ++
10-2 +++ — + + — + ++
10-3 + + +—— —— ± ±




Undiluted +++ + + + — + ++
10-1 +++ ± — — — + ±
10-2 + + +—— —— — —
10-3 —— —— —— —
10-4 —— —— —— —
Ovine, genotype 2
  (Moredun strain)
Undiluted +++ ++ ++ ++ ++ ++ ++
10-1 +++ + ++ + + ++ ++
10-2 +++ ± ± — — + ++
10-3 + + +—— —— — ±
10-4 —— —— —— —
aPolymerase chain reaction (PCR) procedures used for gene fragments: N-COWP = nested Cryptosporidium oocyst wall protein
gene (553 bp, this study); E-COWP = extended COWP (769 bp, this study); COWP = unnested procedure (553 bp, 5); TRAP-C1
= thrombospondin-related adhesive protein Cryptosporidium 1 (506 bp, 6); TRAP-C2 = thrombospondin-related adhesive
protein Cryptosporidium 2 (369 bp, 4); 18S rDNA 1 (422 bp, 8,17); 18S rDNA 2 (435 bp, 18).
bSemiquantitative results on the basis of strength of ethidium bromide staining in electrophoresis gels: strong (+++), moderate
(++), weak (+), very weak (±), and amplification not detected(—).52 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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amplification was achieved only up to 10-2 (Table
1). The two 18S rDNA procedures moderately
amplified DNA to 10-3, with the exception of
genotype 3, which gave only a weak reaction in
the undiluted sample. The three PCRs used for
genotyping (COWP, TRAP-C1, and TRAP-C2) all
gave weaker signals than the N-COWP proce-
dure, and product was sufficient for restriction
enzyme digestion undiluted or at 10-1, except for
genotype 3, in which there was insufficient
amplification with all reactions, and COWP, in
which there was sufficient amplification from the
sample containing genotype 1 to perform
genotyping at the 10-2 dilution (Table 1).
Assessment of N-COWP Procedure
DNA was extracted from 1,680 fecal samples
in which hospital laboratories had reported
detection of Cryptosporidium oocysts by conven-
tional procedures; these samples were from
patients with diarrhea diagnosed in England,
Northern Ireland, or Scotland during 1998-99.
All samples were tested by the unnested COWP
procedure, and those in which no amplicons were
detected were retested by N-COWP. Samples
were reexamined by microscopy if no amplifica-
tion was detected by either COWP and N-COWP
(except for two samples for which there was
insufficient material) and a selection of other
samples: overall, 475 (28%) and 397 (24%) of
samples were retested by IF and MZN,
respectively. Amplification and genotyping were
successful in 95.2% of the samples, 77.6% by
COWP and 17.6% by N-COWP (Table 2). Of the
43 samples in which no oocysts were detected, all
were negative by COWP, N-COWP, and 18S
rDNA-1 PCR. DNA was amplified from two of the
43 microscopy-negative samples by the 18S
rDNA-2 reaction. Five of these microscopy-
negative samples did not amplify DNA when
tested with TRAP-C1.
Of the 35 COWP- and N-COWP-negative
samples in which oocysts were detected after
reexamination (Table 2), DNA was amplified
from 11 (31%) by either 18S rDNA amplifications:
three and four samples by 18S rDNA reactions 1
and 2, respectively, and four samples by both 18S
rDNA amplifications.
Of the 1,600 samples in which DNA was
amplified by either  COWP or N-COWP (Table 2),
731, 209, and 210 were also tested by 18S rDNA
reaction 1, 18S rDNA reaction 2, and TRAP-C2,
respectively. DNA was amplified from 627 (86%),
166 (79%), and 138 (66%) by 18S rDNA reaction 1,
18S rDNA reaction 2, and TRAP-C2, respectively.
Identical genotyping results were obtained by
COWP/N-COWP and Rsa1 digestion of the
TRAP-C1 fragment in all 138 samples in which
amplification of the latter DNA fragment was
achieved: 55 were genotype 1 and 83 genotype 2.
The proportions of genotype 1 and genotype 2
amplifications were similar by COWP or
N-COWP; however, there was a greater than
tenfold increase in the proportions of both mixed
genotypes 1 and 2 and genotype 3 detection by N-
COWP (Table 2).
COWP and N-COWP and Epidemiologic Studies
The COWP gene was amplified from 2,128
cryptosporidiosis cases: 71 from livestock ani-
mals and 2,057 from humans (Table 3). Among
the samples from humans, a genotype was
established by N-COWP but not by COWP in 476
(23.1%) of 2,057, 253 (35.8%) of 706, 13 (25.5%) of
51, and 210 (16.2%) of 1,300 of all samples, and
those collected from drinking waterborne
Table 2. Cryptosporidium oocyst wall protein (COWP) gene analysis of DNA extracted from 1,680 human fecal samples
    No. of COWP genotypes
PCR amplication procedure samples (%) 1 2 1 & 2 3
COWP gene fragment amplified
  Unnested 1,304 (77.6) 381 917 2   4
  Nesteda   296 (17.6)   81 198 7 10
COWP gene fragment not amplifiedb
  Oocysts detected by microscopy     35 (2.1)
  Microscopy not reconfirmedc       2 (0.1)
  Oocysts not reconfirmed by microscopy     43 (2.6)
aAll samples previously negative by unnested procedure.
bBy both unnested and nested procedures.
cInsufficient material available.
PCR = Polymerase chain reaction.53 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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outbreaks, swimming-pool outbreaks, and spo-
radic cases, respectively. Of samples from
livestock animals, 10 (14.1%) of 71 genotypes
were established by N-COWP but not COWP.
Genotype 1 was found in 38.6% of the human
samples, genotype 2 in 59.6%, both genotype 1
and 2 were detected in 1.0%, and genotype 3
(C. meleagridis) in 0.7%.
Genotyping results were obtained from 706
patients infected during seven drinking water-
associated outbreaks: genotype 1 was predomi-
nantly recovered from patients in outbreaks 1 to
4, and genotype 2 from most of the patients in
outbreaks 5 to 7 (Table 3). Genotyping results
were obtained from 51 patients during five
swimming pool-associated outbreaks (Table 3).
Two of these outbreaks (8 and 10) were due to a
single genotype, and the remaining three (9, 11,
and 12) involved both genotypes 1 and 2 (Table 3).
Two samples from swimming pool outbreak 6,
which were from a single patient, yielded
genotype 1 at first and both genotypes 1 and 2 six
days later. Of 1,300 sporadic cases, 34.0% were
genotype 1, 64.1% genotype 2, 1% were both
genotypes 1 and 2, and 9% were genotype 3
(C. meleagridis).
Conclusions
Human cryptosporidiosis has multiple poten-
tial host reservoirs of infection and multiple
routes of transmission (1,2). Molecular biologic
methods have allowed identification of two major
genotypes within C. parvum (the principal
infectious agent for human cryptosporidiosis)
with two transmission cycles. The application of
genotyping techniques may therefore provide a
better understanding of the epidemiology of
cryptosporidiosis, including different routes of
transmission.
Epidemiologic studies of cryptosporidiosis
have incorporated results from genotyping
C. parvum (4,26-29), although these have been
applied to relatively few samples. For example,
among the estimated 400,000 cases associated
with the 1993 waterborne outbreak in Milwaukee
(30), genotyping data are available for five
patients (all genotype 1 [4,26]). However,
C. parvum genotype 1 was implicated in
outbreaks associated with drinking and food, as
well as person-to-person transmission in a day-
care center and attendance at a water park (4,26-
29). C. parvum genotype 2 was also associated
with waterborne outbreaks, contaminated apple
juice, and contact with cows (4,26,27). To
investigate the epidemiology of cryptosporidiosis,
we have described simple methods for the
extraction of cryptosporidium DNA from whole
feces and applied genotyping techniques to
several hundred samples (8,10). We applied these
techniques, together with the development and
Table 3. Cryptosporidium oocyst wall protein (COWP) gene analysis of DNA from 2,057 humans and 71 livestock animals
COWP genotypes
1 2 1 & 2 3 Reference
Humans
  2,057 cases 795 1,227 20 15 This study
Drinking water-associated outbreaks
    1 140       2   3   0     20,21
    2 158     14   1   1        22
    3     4       0   0   0        20
    4   15       0   0   0        23
    5     0       6   0   0        24
    6     0     25   0   0        24
    7     4   331   0   2        24
Swimming pool-associated outbreaks
    8     3       0   0   0        24
    9     6       3   0   0        25
  10     0     10   0   0        25
  11     9       1   3   0        25
  12   14       2   0   0        25
Sporadic human cases 442   833 13 12 8, this study
Livestock animals
  Calves, lambs     0     71   0   0 This study54 Emerging Infectious Diseases Vol. 7, No. 1, January–February 2001
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application of a sensitive PCR protocol (N-COWP),
to >2,000 samples. Our techniques are less labor
intensive than other methods (11,26,27) and
allow analysis of large numbers of samples: we
estimate that 1,000 samples can be extracted and
genotyped within 6 months by one scientist
working full time.
The N-COWP genotyping protocol is more
sensitive than three unnested procedures
(COWP, TRAP-C1, and TRAP-C2) also used for
genotyping. The higher copy number of the 18S
rDNA genes means that PCR procedures for
these are likely to be more sensitive than those
for the COWP, TRAP-C1, and TRAP-C2 gene
sequences, and our data are consistent with this
observation: the 18S rDNA genes occur as five
copies (31), but the COWP, TRAP-C1 and TRAP-
C2 genes occur as single copies per genome (32).
Nested procedures for a single copy gene (the
dihydrofolate reductase gene) and 18S rDNA
genes were most sensitive when 11 PCR
techniques for genotyping of Cryptosporidium
were compared, although these studies were
performed on DNA extracted from four
semipurified oocyst suspensions (33).
One of the 18S rDNA amplifications reported
elsewhere for genotyping (33) also amplified
DNA from different Cryptosporidium species.
However, Sulaiman and colleagues (33) reported
that a COWP gene can be amplified from
C. serpentis and C. muris (although the PCR
products were faint) and that these are distinct
from C. parvum. C. wrairi (5) and C. meleagridis
(34) can be distinguished by PCR-RFLP analysis.
We also reported that a single base mismatch (T
to C substitution) occurs in the Cry9 COWP
primer annealing region in genotype 3
(C. meleagridis) (13), which may account for the
increased efficiency in amplification with the N-
COWP procedure, as well as the faint amplifica-
tions reported for C. serpentis and C. muris (33).
We are investigating the use of our extraction
and PCR protocols described for identification of
Cryptosporidium species, especially in samples
that did not amplify COWP sequences but did
amplify cryptosporidium 18S rDNA and in which
oocysts were detected by microscopy.
A diagnosis of cryptosporidiosis can be
established by examination of stained fecal
smears prepared either directly from feces or
after concentration (flotation) procedures (14).
Although symptomatic cryptosporidiosis in hu-
mans is generally associated with large numbers
of oocysts in the feces, infections occur in which
oocysts cannot be detected by microscopy (14,35).
Our DNA extraction method is based on whole
feces; therefore, target DNA may be derived not
only from oocysts, but also from other stages in
the life cycle of this parasite. However, as found
in experiments seeding DNA into feces, oocysts
are the most likely source of DNA and the
estimated sensitivity of the N-COWP reaction is
equivalent to <500 oocysts/g of feces (Pedraza-
Díaz et al., unpub data). Future studies will
examine specimens from patients with diarrhea
due to Cryptosporidium (and other intestinal
pathogens) to establish the true sensitivity of this
method for patient samples without detectable
oocysts. Failure to detect oocysts may result from
degradation of both oocysts and DNA, although
DNA has been isolated and successfully
amplified from whole fecal samples stored at 4ºC
for >5 years (8).
The N-COWP procedure detected a higher
proportion of samples containing both genotypes
1 and 2. Further DNA sequence-based analysis
indicates that these are true dual infections, not
infections due to recombination within C. parvum
(Pedraza-Díaz et al., unpub data). The increased
rate of mixed infections identified by the N-
COWP procedure is consistent with our data
suggesting that the two genotypes may occur in
feces at differing concentrations (8). Previously
undetectable mixtures of genotypes may also
explain apparent genetic changes due to selective
growth as a result of host specificity after passage
through different animals (7,36).
In this large series of cryptosporidiosis cases,
all samples from livestock yielded genotype 2,
consistent with previous results (9). Of >2,000
samples from humans, 38.6% were due to
genotype 1, 59.6% to genotype 2, both genotypes 1
and 2 were recovered from 1%, and 0.7% were due
to genotype 3 (C. meleagridis). There are
relatively few comparative data analyzing larger
series from humans, although Sulaiman et al.
(26) reported that of 50 human cases, 82% were
due to genotype 1 and 18% to genotype 2. These
results with respect to the proportions of the
C. parvum genotypes 1 and 2 differed markedly
from our data for the United Kingdom; however,
further results showed marked seasonal and
geographic differences (34).
Data are presented here on 709 patients
infected during seven drinking-waterborne
outbreaks (51% of the microbiologically confirmed55 Vol. 7, No. 1, January–February 2001 Emerging Infectious Diseases
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cases). Four of the outbreaks were almost
exclusively due to genotype 1 and three to
genotype 2. Data from field epidemiologic
observations (23,24) suggest that contamination
of water by sheep feces was involved in the three
outbreaks due to genotype 2. All outbreaks
occurred in the spring when lambing (as well as
outbreaks of cryptosporidiosis in sheep) occurs
most commonly in the United Kingdom (37). In
contrast, the likely source of C. parvum in the
four drinking-waterborne outbreaks predomi-
nantly due to genotype 1 was by contamination
with human sewage; these occurred throughout
the year. Outbreaks 1 and 2 occurred after heavy
rain (20-22), and untreated sewage overflowing
from storm drains may be a contributing factor.
Among the five outbreaks associated with
swimming pools, one was due to genotype 1, one
to genotype 2, and the remaining three to both
genotypes 1 and 2. Outbreaks in swimming pools
may be associated with fecal contamination from
a single infected person (especially in toddler
pools), so that a single genotype is recovered from
the patients. However, outbreaks may also be due
to more general problems such as contamination
with sewage, poor disinfection, or inadequate
maintenance of filtration equipment (25).
Our data on 1,300 sporadic cases, as well as
further epidemiologic analysis (34), indicate that
patients reporting contact with animals or farms
were almost all infected by genotype 2; the spring
peak in cases was almost exclusively due to
genotype 2; genotype 1 was significantly more
common in patients infected during the late
summer-autumn peak and in those with a history
of foreign travel; and there were distinct
geographic variations in the distribution of the
genotypes.
In summary, we described methods for the
analysis of Cryptosporidium genotypes and
demonstrated their application to a large series
of samples. These approaches, together with the
development of more discriminatory typing
methods (28), should increase understanding of
the epidemiology of cryptosporidiosis. Methods of
improved sensitivity, such as those described
here, will also be invaluable in detection and
genotyping of Cryptosporidium in environmen-
tal samples.
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